DEFINITIVE CONTRACT
Active75F40126C00059
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$511.2K
obligated · signed 2 weeks ago
TO ADVANCE THE DEVELOPMENT, EVALUATION, AND PREDICTIVE MODELING OF LEVONORGESTREL INTRAUTERINE SYSTEMS (LNG-IUSS) BY INTEGRATING ACCELERATED TESTING, REAL-TIME RELEASE STUDIES, MICROSTRUCTURAL ANALYSIS, AND AI/ML-DRIVEN MODELING APPROACHES.
Performance timeline
Start
Sep 30, 2026
Current end
Sep 29, 2028
Potential end
Sep 29, 2029
with all options
Loading status
Estimated start: Sep 29, 2028
UNIVERSITY OF CONNECTICUT
Contract 75F40126C00059
UEI
WNTPS995QBM7
Parent Company
UNIVERSITY OF CONNECTICUT
Capabilities & Certifications
Headquarters Location
Congressional District: 02
Current Obligation
$511,219
Base + Exercised Options
$511,219
Total Ceiling Value
$789,844
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; BASIC RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.